- FILTERS Advanced
- Product Type
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- CE / IVD
- Clone ID
- EXCLUDE FILTERS
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- Clone ID
| Name | Art no | Species Reactivity | Application | Conjugation | Clone | Size | Price |
|---|---|---|---|---|---|---|---|
|
154-32179
|
|
ELISA
|
unconjugated
|
RM3
|
100 µl
|
||
|
154-18289
|
|
Dot blot, ELISA
|
|
|
1 ea
|
||
|
154-28636
|
|
ELISA, IHC
|
|
8G4
|
100 µg
|
||
|
154-14489
|
|
|
|
|
1 mg
|
||
|
154-28812
|
|
ELISA, IF
|
|
1F8
|
100 µg
|
||
|
154-16563
|
|
FC
|
|
|
1 mg
|
||
|
154-20723
|
|
Dot blot, ELISA, ICC, IHC
|
|
RM236
|
50 µg
|
||
|
154-20722
|
|
Dot blot, ELISA, ICC, IHC
|
|
RM231
|
50 µg
|
||
|
154-19655
|
|
IP
|
|
|
100 µl
|
||
|
154-501270
|
|
|
|
|
96 wells
|
||
|
154-30773
|
|
ELISA, IHC, IP
|
|
1D9
|
100 µg
|
||
|
154-16625
|
|
FC
|
|
|
50 µg
|
||
|
154-500840
|
|
|
|
|
96 wells
|
||
|
154-500830
|
|
|
|
|
96 wells
|
||
|
154-M1964
|
|
ELISA
|
|
|
50 µl
|
||
|
154-M1963
|
|
ELISA
|
|
|
50 µl
|
||
|
154-M1977
|
|
ELISA
|
|
|
50 µl
|
||
|
154-M1950
|
|
ELISA
|
|
|
100 µl
|
||
|
154-M1951
|
|
ELISA
|
|
|
50 µl
|
||
|
154-27320-25
|
|
|
|
|
25 mg
|
||
|
154-34551
|
|
|
|
|
50 µg
|
||
|
154-10803
|
|
|
|
|
100 µg
|
||
|
154-120111
|
|
FC, IF, IHC
|
|
7B1
|
1 ea
|
||
|
154-33984
|
|
|
|
|
100 µg
|
||
|
154-32024
|
|
|
|
|
100 µg
|
||
|
154-10010712
|
|
FC, IF
|
FITC
|
|
500 µl
|
||
|
154-32322
|
|
IHC
|
|
RM393
|
100 µl
|
||
|
154-37157
|
|
FC
|
|
10F381 (Rituximab)
|
200 µg
|
||
|
154-37158
|
|
FC, IP
|
|
hL22 (Epratuzumab)
|
200 µg
|
||
|
154-32339
|
|
IHC
|
|
RM418
|
100 µl
|
||
|
154-37169
|
|
FC
|
|
Daclizumab
|
200 µg
|
||
|
154-37159
|
|
FC, IF
|
|
hP67.6 (Gemtuzumab)
|
200 µg
|
||
|
154-10004835
|
|
FC, ICC
|
|
ICO-115
|
1 ea
|
||
|
154-10208
|
|
FC, IF
|
FITC
|
ICO-115
|
1 ea
|
||
|
154-10004599
|
|
FC, ICC, IHC
|
|
RIV7
|
1 ea
|
||
|
154-37160
|
|
ELISA, FC, IHC
|
|
CE9.1 (Clenoliximab)
|
200 µg
|
||
|
154-10010530
|
|
FC
|
FITC
|
RIV7
|
1 ea
|
||
|
154-37156
|
|
IF
|
|
IDEC-131 (Toralizumab)
|
200 µg
|
||
|
154-10004715
|
|
FC, ICC, IHC
|
|
RIV11
|
1 ea
|
||
|
154-29254
|
|
ICC
|
|
4901
|
100 µl
|
||
|
154-160111
|
|
FC
|
FITC
|
CX111
|
250 µg
|
||
|
154-160120
|
|
FC, IF
|
PE
|
CX111
|
1 ea
|
||
|
154-160113
|
|
FC, ICC, IF
|
FITC
|
CX229
|
1 ea
|
||
|
154-14713
|
|
FC
|
FITC
|
|
1 ea
|
||
|
154-10349
|
|
FC, IF
|
FITC
|
C-11
|
1 ea
|
||
|
154-10478
|
|
FC, IF
|
PE
|
C-11
|
1 ea
|
||
|
154-30185
|
|
IHC, IF, ELISA
|
|
4.00E+09
|
100 µg
|
||
|
154-13483
|
|
ELISA
|
Biotin
|
64B814.1
|
1 ea
|
||
|
154-20094
|
|
ELISA, IP
|
|
7.00E+06
|
100 µg
|
||
|
154-37166
|
|
FC
|
|
C225 (Cetuximab)
|
200 µg
|